GlassScriptPhysician profile
Sandra Noel
NPI 1699426403
$8,256.63
in general payments reported to CMS, 2019-2025
7 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.74 · 2023: $2,975 · 2024: $3,865 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,231.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,930.28 | 2023-2025 | Biktarvy, Descovy, Yeztugo |
| Viiv Healthcare Company | $3,500.84 | 2023-2025 | Cabenuva, Dovato, Apretude |
| Janssen Biotech, INC. | $503.70 | 2023 | Symtuza |
| Abbvie INC. | $131.63 | 2022-2025 | |
| Janssen Products, LP | $125.00 | 2023 | Symtuza |
| Merck Sharp & Dohme LLC | $34.62 | 2024 | Pifeltro, Delstrigo |
| Glaxosmithkline, LLC. | $30.56 | 2024 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.